Company Analysis

NeOnc Technologies Holdings, Inc. (NTHI)

Nasdaq: NTHI · Pharmaceutical Preparations · Calabasas, CA · filing with the SEC since 2023
Grade3.5
◀ Past 4.6● Present 1.6▶ Future 4.6
4 est.

Who runs NeOnc Technologies Holdings, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Heshmatpour Amir F
CEO, President. First filing Mar 2025, latest Nov 12, 2026, 18 filings in all.
Officers reporting now
5
of 8 people with a filing in the last fifteen months
Directors reporting now
3
13 people on the record since 2025
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Heshmatpour Amir FCEO, PresidentMar 2025Nov 12, 2026none
Chen Thomas CCMOMar 2025Nov 12, 2026none
Garnett KeithlyCFOMar 2025Sep 18, 20261 · $0.00
Neman-Ebrahim YoushaChief Clinical OfficerJun 2025Apr 24, 2026none
Suh, David Jr.Chief Accounting OfficerMar 2026Apr 13, 2026none
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Shomali NasimdirectorJul 2026Jul 13, 2026none
Chiang Ming-Fu (Alan)directorMar 2025Nov 24, 2025none
Puri Ishwar KanwardirectorSep 2025Sep 5, 2025none
Earlier names on the record7, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton NTHI · research, not advice